CIK 0001455365
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- 4 Grant or award CEO & President acquired 213,973 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $2.66 ($26,550)
- 4 Open-market buy Director bought 16,064 shares at $2.65 ($42,565)
- 4 Open-market buy Director bought 16,064 shares at $2.65 ($42,565)
- 4 Open-market buy Director bought 71,000 shares at $1.40 ($99,400)
- 4 Open-market buy Director bought 71,000 shares at $1.40 ($99,400)
- 4 Open-market buy CEO & President bought 12,000 shares at $1.30 ($15,600)
- 4 Open-market buy Director bought 12,500 shares at $1.20 ($15,000)
- 4 Open-market buy Director bought 1,500,000 shares at $1.20 ($1,800,000)
- 4 Open-market buy Director bought 1,500,000 shares at $1.20 ($1,800,000)
- 4 Other disposition 10% owner disposed of 2,489,682 shares (other)
- 4 Other acquisition Director acquired 22,461 shares (other)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 6 · 117 filings